Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus.
about
Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus.
@en
Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus.
@nl
type
label
Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus.
@en
Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus.
@nl
prefLabel
Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus.
@en
Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus.
@nl
P2093
P2860
P1476
Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus
@en
P2093
Daiju Fukuda
Gulinu Maimaituxun
Hirotsugu Yamada
Hotimah Masdan Salim
Ken-Ichi Aihara
Koji Yamaguchi
Masashi Akaike
Masataka Sata
Michio Shimabukuro
Saori Hama
P2860
P2888
P356
10.1186/S13098-017-0275-4
P577
2017-10-04T00:00:00Z
P6179
1092060369